A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. While the majority of these hematomas resolve by themselves, some can become large and can cause complications. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient.
A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is also known as a subchorionic hemorrhage, subchorionic bleed, or subchorionic collection. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. The hematoma is usually caused by a tear in the placenta, which is the organ that provides the fetus with oxygen and nutrients. The tear can be caused by trauma, such as a car accident, or it can occur spontaneously. The hematoma can range in size from a few millimeters to several centimeters.
Subchorionic hematomas are usually diagnosed during an ultrasound. The ultrasound will show a collection of fluid between the chorion and the amnion. The size of the hematoma will be measured and monitored over time to determine if it is getting larger or smaller. If the hematoma is small and is not causing any symptoms, it can usually be monitored without any intervention. The patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus. If the hematoma is large, the patient may be placed on bed rest and medications may be prescribed to reduce the risk of preterm labor. If the hematoma is very large, the patient may be referred to a maternal-fetal medicine specialist for further evaluation and management.
Subchorionic hematomas can cause complications, such as preterm labor, placental abruption, and fetal growth restriction. The risk of these complications increases with the size of the hematoma. The risk of preterm labor is increased if the hematoma is larger than 20 millimeters. Placental abruption is a serious condition in which the placenta separates from the uterus, and it is more likely to occur if the hematoma is larger than 30 millimeters. Fetal growth restriction is a condition in which the fetus does not grow at the expected rate, and it is more likely to occur if the hematoma is larger than 40 millimeters.
It is important for obstetricians to chart the course of the hematoma size in order to determine the best course of action for the patient. The size of the hematoma should be measured at each ultrasound, and the measurements should be compared to the previous measurements. The rate of growth should also be monitored, as this can help to determine if the hematoma is increasing in size or not. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
Subchorionic hematomas are a common complication of pregnancy, and they can cause serious complications if they become large. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
1.
Lesser-known lobular breast cancer on the rise in U.S. women
2.
Study finds that AI is better at forecasting the risk of developing cancer.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
5.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
1.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology
4.
Digital Blood Cell Morphology Libraries for Longitudinal Hematologic Monitoring
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Best Practices in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation